Skip to main content
. 2019 Nov 15;2019:7419249. doi: 10.1155/2019/7419249

Figure 3.

Figure 3

OCA pretreatment alleviated fetal intrauterine growth restriction during E2-induced cholestasis. All pregnant mice except controls were s.c. injected with E2 (0.625 mg/kg) once daily from GD13 to GD17. In the OCA+E2 groups, pregnant mice were administered with OCA (5 mg/kg) by gavage once daily from GD12 to GD17. All dams were sacrificed on GD18. (a) Fetal mortality per litter. (b) Fetal weight per litter and fetal crown-rump length per litter. (c) Rate of IUGR per litter. All data were expressed as means ± S.E.M. (n = 12 for each group). ∗∗P < 0.01.